Kintsugi focuses on mental health care within the healthcare industry. The company offers an application programming interface (API)-first platform that uses voice biomarker technology to identify and prioritize mental health challenges, integrating with various healthcare systems to facilitate timely care. Kintsugi primarily serves the healthcare sector, providing tools for telehealth, call centers, and remote patient monitoring. It was founded in 2019 and is based in Berkeley, California.

Sonde Health specializes in health technology and focuses on voice-enabled symptom detection and monitoring within the healthcare sector. The company offers a platform that analyzes vocal features to assess mental, cognitive, and respiratory health, providing actionable insights for early detection and management of health conditions. It was founded in 2015 and is based in Boston, Massachusetts.

Thymia specializes in mental health technology, providing AI-powered assessments to objectively measure and monitor mental health conditions. The company offers tools that leverage machine learning and neuropsychology to accurately identify mental illness symptoms using a unique combination of voice, video, and behavioral data. Thymia primarily serves healthcare providers, payers, and employers with its mental health evaluation and monitoring solutions. It was founded in 2020 and is based in London, United Kingdom.

Modality.AI is a company that assesses neurological and psychiatric conditions using a multimodal platform in the clinical research sector. The company provides automated analysis of speech, facial expressions, and motor functions for clinical trials, both in-clinic and remotely, without requiring specialized equipment or personnel. Modality.AI serves the pharmaceutical and biotechnology industries by offering tools for clinical assessments. It was founded in 2018 and is based in San Francisco, California.

Deliberate AI focuses on the application of artificial intelligence in the healthcare sector, specifically in the assessment of psychiatric and neurological health. The company's main service involves the extraction of features from audio-visual signals and other modalities to compute clinically significant biomarkers and predictive models for psychiatric and neurologic disorders. Its services primarily cater to the life sciences industry, including biopharma and medical device companies. It was founded in 2020 and is based in New York, New York.

Click Therapeutics focuses on the development and commercialization of software-based prescription medical treatments within the healthcare sector. The company offers digital therapeutics and software-enhanced drugs that aim to provide clinical applications in various therapeutic areas. Click Therapeutics serves the healthcare industry, with a focus on psychiatric, neurological, oncological, cardiological, and immunological therapeutic areas. It was founded in 2012 and is based in New York, New York.